B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis.
about
Immunotherapy of Childhood SarcomasNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesAdoptive cell therapy for sarcomaImaging Biomarkers in ImmunotherapyIncreased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in miceCD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingB7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceDecreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitorsImmunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αB7-H3 protein expression in a murine model of osteosarcoma.The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.Bone microenvironment signals in osteosarcoma development.Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies.The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.Genetic factors conferring metastasis in osteosarcoma.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.B7-H3 in tumors: friend or foe for tumor immunity?Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.Identification and analysis of key genes in osteosarcoma using bioinformatics.Clinical significance of serum soluble B7-H3 in patients with osteosarcomaB7H3 As a Promoter of Metastasis and Promising Therapeutic Target
P2860
Q26795369-BCEC9093-B48A-4B1C-9A9E-E3342AC9283FQ26825652-22F78476-B218-475A-830C-67E3CA6C5998Q27009541-95F676A3-4F24-46B1-945C-C8EA9A8AFF51Q28079871-97967E26-5B49-44FC-B8EE-BF5322DCE5F2Q33598323-9F52BCC7-A507-422C-ADEC-07EBA5CF384CQ35506606-6C76E91E-93FA-40E1-B36A-C0F7B4791E00Q35530644-8E62A5C8-D4AD-47D9-8704-4D02109146DCQ35543730-BCDA0966-6E75-4986-B055-62883E4FE436Q35751840-2E8D8549-4906-46A2-945A-2494998C095DQ35867721-2A9EA130-F3EB-42F6-896E-3C883562786BQ36444198-0B3531AE-DEFF-428F-A21B-39A642A6AC6EQ36597354-389E63BB-DE92-43D9-AB3D-AA8DE8746095Q36916365-0C71956B-BEEA-419D-BAC2-0167A52C7C78Q36921665-4B192CB2-E3F6-4D86-A869-3FBA8E2D74A3Q37001496-6FDE129A-A3EE-4307-B67E-23834E74EE27Q37362510-C9C87BC9-F9A0-4D0E-B3B7-13749A3E46EFQ37697212-ADFA5A8C-84EA-4BD4-9382-364302E2FCEEQ37718360-D55BEA16-75AB-4BB7-80AA-7984C320565FQ38454980-6885A49A-4171-4848-98B5-15D0474FCDDDQ38670099-27ED52D6-90AA-4BF2-88B3-094F678243C9Q38745141-6387AC3F-6943-4456-BD01-CEDD30D2E59BQ38806986-31ED17D2-5FB4-4CED-9AFD-A9405177EBD0Q39160982-B6958045-951E-467B-BC66-D5499B1E8F99Q39446788-80B7FCD8-3481-4E3E-B5BB-4B862BB429D2Q41809391-E9AC9685-A6FA-4121-A1FA-53A177CA0E8EQ47150218-3EFE5782-6FAB-4970-BD5D-066EB6E97627Q47233613-A896BAC7-CB85-4BA5-90F8-86A4D1167C18Q48131888-80BC29D2-F1CD-47FE-8F8A-F69225CA03E6Q49788841-881E3986-B68B-42FE-8DDF-8D3020507B21Q57071638-02FA5D04-9F89-4949-ACCB-D7080BB733C3Q57176931-C64D2B1B-8BDF-46E3-9CFA-F75509F8805D
P2860
B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@ast
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@en
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@nl
type
label
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@ast
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@en
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@nl
prefLabel
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@ast
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@en
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@nl
P2093
P2860
P1433
P1476
B7-H3 is overexpressed in pati ...... aggressiveness and metastasis.
@en
P2093
Baoen Shan
Guochuan Zhang
Yingze Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0070689
P407
P577
2013-08-05T00:00:00Z